A framework for using cost-effectiveness analysis to support pricing and reimbursement decisions for new pharmaceuticals in a context of evolving treatments, prices and evidence

Beth Woods; Alfredo Daniel Palacios; Mark Sculpher

A framework for using cost-effectiveness analysis to support pricing and reimbursement decisions for new pharmaceuticals in a context of evolving treatments, prices and evidence

Beth Woods, Alfredo Daniel Palacios, Mark Sculpher

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	PharmacoEconomics
Publication status	Accepted/In press - 23 Oct 2024

Bibliographical note

This is an author-produced version of the published paper. Uploaded in accordance with the University’s Research Publications and Open Access policy.

Embargoed Document

Main text 22102024 CLEAN
Accepted author manuscript, 543 KB
Licence: CC BY
Embargo ends: 31/12/99

Cite this

@article{e51e380a4d0d47a7a0704335bcf951b9,

title = "A framework for using cost-effectiveness analysis to support pricing and reimbursement decisions for new pharmaceuticals in a context of evolving treatments, prices and evidence",

author = "Beth Woods and Palacios, {Alfredo Daniel} and Mark Sculpher",

note = "This is an author-produced version of the published paper. Uploaded in accordance with the University{\textquoteright}s Research Publications and Open Access policy. ",

year = "2024",

month = oct,

day = "23",

language = "English",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

}

TY - JOUR

T1 - A framework for using cost-effectiveness analysis to support pricing and reimbursement decisions for new pharmaceuticals in a context of evolving treatments, prices and evidence

AU - Woods, Beth

AU - Palacios, Alfredo Daniel

AU - Sculpher, Mark

N1 - This is an author-produced version of the published paper. Uploaded in accordance with the University’s Research Publications and Open Access policy.

PY - 2024/10/23

Y1 - 2024/10/23

M3 - Article

SN - 1170-7690

JO - PharmacoEconomics

JF - PharmacoEconomics

ER -